Literature DB >> 25289524

Effect of parthenolide on growth and apoptosis regulatory genes of human cancer cell lines.

Anees A Al-Fatlawi1, Atheer A Al-Fatlawi, Md Irshad, Ayaz Ahmad.   

Abstract

CONTEXT: Parthenolide (a sesquiterpene lactone), a bioactive compound of Tanacetum parthenium (L.) Schultz Bip. (Asteraceae) herb, has been reported for antioxidant and anticancer activities.
OBJECTIVE: The present study evaluated the effect of parthenolide on growth and apoptosis-regulatory genes of human cervical cancer (SiHa) and breast cancer (MCF-7) cell lines.
MATERIALS AND METHODS: The cytotoxic activity of parthenolide (3.5-21 µM) was examined by MTT and LDH assays at 24 and 48 h time intervals. Apoptotic activity was evaluated by expression analysis of multiple apoptosis-regulatory genes (i.e., p53, Bcl-2, Bax, caspase-3, -6, and -9) by reverse transcriptase-PCR and DNA fragmentation assay.
RESULTS: Parthenolide inhibited the growth of SiHa and MCF-7 cell lines in a concentration-dependent manner at 24 and 48 h time intervals (p < 0.001). The IC50 value of parthenolide against SiHa and MCF-7 cells were 8.42 ± 0.76 and 9.54 ± 0.82 μM, respectively. Parthenolide-treated cells showed up-regulation of p53, Bax, caspase-3, -6, and -3 genes and down-regulation of Bcl-2 gene (p ≤ 0.008). At IC50, the p53 gene was up-regulated by 9.67- and 3.15-fold in SiHa and MCF-7 cells, respectively. The Bax to Bcl-2 ratio was 3.4 and 2.3 for SiHa and MCF-7 cells, respectively. Also, the fragmented genomic DNA in parthenolide-treated cells showed the signs of apoptosis.
CONCLUSION: Our study endorsed the biological activity of parthenolide and demonstrated the parthenolide-induced growth inhibition and apoptosis in SiHa and MCF-7 cells by modulating the expression of apoptosis-regulatory genes.

Entities:  

Keywords:  Bax; Bcl-2; DNA fragmentation; caspases; cytotoxicity; p53

Mesh:

Substances:

Year:  2014        PMID: 25289524     DOI: 10.3109/13880209.2014.911919

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  7 in total

1.  Parthenolide attenuates 7,12-dimethylbenz[a]anthracene induced hamster buccal pouch carcinogenesis.

Authors:  Nagarethinam Baskaran; Govindan Sadasivam Selvam; Subramani Yuvaraj; Albert Abhishek
Journal:  Mol Cell Biochem       Date:  2017-08-12       Impact factor: 3.396

Review 2.  Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties.

Authors:  Daniela Carlisi; Marianna Lauricella; Antonella D'Anneo; Anna De Blasio; Adriana Celesia; Giovanni Pratelli; Antonietta Notaro; Giuseppe Calvaruso; Michela Giuliano; Sonia Emanuele
Journal:  Biomedicines       Date:  2022-02-21

Review 3.  Natural and Synthetic Lactones Possessing Antitumor Activities.

Authors:  Younghoon Kim; Sandip Sengupta; Taebo Sim
Journal:  Int J Mol Sci       Date:  2021-01-21       Impact factor: 6.208

4.  Parthenolide facilitates apoptosis and reverses drug-resistance of human gastric carcinoma cells by inhibiting the STAT3 signaling pathway.

Authors:  Hua Li; Hang Lu; Meng Lv; Qingsheng Wang; Yuping Sun
Journal:  Oncol Lett       Date:  2018-01-08       Impact factor: 2.967

5.  Box-Behnken Design (BBD)-Based Optimization of Microwave-Assisted Extraction of Parthenolide from the Stems of Tarconanthus camphoratus and Cytotoxic Analysis.

Authors:  Perwez Alam; Nasir Ali Siddiqui; Md Tabish Rehman; Afzal Hussain; Ali Akhtar; Showkat R Mir; Mohamed Fahad Alajmi
Journal:  Molecules       Date:  2021-03-26       Impact factor: 4.411

Review 6.  Combination Anticancer Therapies Using Selected Phytochemicals.

Authors:  Wamidh H Talib; Dima Awajan; Reem Ali Hamed; Aya O Azzam; Asma Ismail Mahmod; Intisar Hadi Al-Yasari
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927

7.  High resolution UHPLC-MS characterization and isolation of main compounds from the antioxidant medicinal plant Parastrephia lucida (Meyen).

Authors:  Carlos Echiburu-Chau; Leyla Pastén; Claudio Parra; Jorge Bórquez; Andrei Mocan; Mario J Simirgiotis
Journal:  Saudi Pharm J       Date:  2017-03-14       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.